cabozantinib plus atezolizumab for patients with metastatic castration-resistant prostate cancer
Published 3 years ago • 120 plays • Length 8:38Download video MP4
Download video MP3
Similar videos
-
12:41
cabozantinib in combination with atezolizumab in patients with mcrpc
-
5:04
cabozantinib with atezolizumab for mcrpc
-
5:05
cabozantinib plus atezolizumab for non-clear cell renal cell carcinoma
-
1:19
dr. agarwal on the safety of cabozantinib/atezolizumab in mcrpc
-
5:42
atezolizumab with radium-223 in metastatic castrate-resistant prostate cancer
-
1:32
bradley mcgregor, md, shares presented data investigating atezolizumab and cabozantinib in mcrpc
-
0:37
tanya dorff, md, elaborates on data investigating atezolizumab and cabozantinib in prostate cancer
-
3:32
disease control with cabozantinib plus atezolizumab in crpc - medpage today
-
0:51
rana mckay, md, elaborates on presented data investigating atezolizumab and cabozantinib in mcrpc
-
1:13
dr. agarwal on data with cabozantinib/atezolizumab in mcrpc
-
2:49
sequencing atezolizumab and sipuleucel-t for castration resistant prostate cancer
-
0:51
dr. pal on the rationale for adding cabozantinib to atezolizumab in prostate cancer
-
1:41
dr. posadas discusses cabozantinib in prostate cancer
-
1:01
oliver sartor, md, elaborates on presented data investigating atezolizumab and cabozantinib in mcrpc
-
1:54
dr. agarwal on developing biomarkers of response to cabozantinib/atezolizumab in mcrpc
-
1:53
contact-2: cabozantinib and atezolizumab in mcrpc
-
2:31
asco 2022: efficacy of cabozantinib atezolizumab to treat urothelial carcinoma
-
0:47
tom beer, md on the data presented at asco gu20 investigating atezolizumab and cabozantinib in mcrpc
-
4:43
asco: cabozantinib and atezolizumab in urothelial cancer